Oct. 28 Business Watch: More plants closing in Europe, Novartis to pay $12 billion for biotech firm
C&EN, 28 October 2025
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
C&EN, 28 October 2025
Hovione announced today the expansion of its New Jersey facility in East Windsor, USA.
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Hovione has once again solidified its position as a top employer.
Pharmaceutical Technology, 26 December 2025
Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey facility in East Windsor, USA